Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/3060
Sequence, infectivity and replication kinetics of SARS-CoV-2 isolated from COVID-19 patients in Canada
Arinjay Banerjee.
Jalees A. Nasir.
Patrick Budylowski.
Lily Yip.
Patryk Aftanas.
Natasha Christie.
Ayoob Ghalami.
Kaushal Baid.
Amogelang R. Raphenya.
Jeremy A Hirota.
Matthew S. Miller.
Allison J McGeer.
Mario A Ostrowski.
Robert A. Kozak.
Andrew G McArthur.
Karen Mossman.
Samira Mubareka.
Acceso Abierto
Atribución-NoComercial-SinDerivadas
10.1101/2020.04.11.037382
SARS-CoV-2 emerged in December 2019 in Wuhan, China and has since infected over 1.5 million people, of which over 107,000 have died. As SARS-CoV-2 spreads across the planet, speculations remain about the range of human cells that can be infected by SARS-CoV-2. In this study, we report the isolation of SARS-CoV-2 from two cases of COVID-19 in Toronto, Canada. We determined the genomic sequences of the two isolates and identified single nucleotide changes in representative populations of our virus stocks. More importantly, we tested a wide range of human immune cells for productive infection with SARS-CoV-2. Here we confirm that human primary peripheral blood mononuclear cells (PBMCs) are not permissive for SARS-CoV-2. As SARS-CoV-2 continues to spread globally, it is essential to monitor single nucleotide polymorphisms in the virus and to continue to isolate circulating viruses to determine viral genotype and phenotype using in vitro and in vivo infection models.
www.biorxiv.org
2020
Artículo
https://www.biorxiv.org/content/10.1101/2020.04.11.037382v2.full.pdf
Inglés
VIRUS RESPIRATORIOS
Aparece en las colecciones: Artículos científicos

Cargar archivos:


Fichero Tamaño Formato  
1103382.pdf4.44 MBAdobe PDFVisualizar/Abrir